title: Molecular basis for therapy resistance.
abstract: Chemoresistance remains the main reason for therapeutic failure in breast cancer as well as most other solid tumours. While gene expression profiles related to prognosis have been developed, so far use of such signatures as well as single markers has been of limited value predicting drug resistance. Novel technologies, in particular with regard to high through-put sequencing holds great promises for future identification of the key "driver" mechanisms guiding chemosensitivity versus resistance in breast cancer as well as other malignant conditions.
authors.affiliation: Section of Oncology, Institute of Medicine, University of Bergen, Norway. per.lonning@helse-bergen.no
authors.forename: Per E
authors.initials: PE
authors.lastname: Lønning
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human
references.citation: Expert Opin Investig Drugs. 2009 Nov;18(11):1735-51
references.pmid: 19780706
references.citation: J Clin Oncol. 1999 May;17(5):1474-81
references.pmid: 10334533
references.citation: Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):819-26
references.pmid: 16467094
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6789-95
references.pmid: 15501955
references.citation: Breast. 2003 Oct;12(5):320-7
references.pmid: 14659147
references.citation: N Engl J Med. 2004 Dec 30;351(27):2817-26
references.pmid: 15591335
references.citation: J Clin Oncol. 2010 Jan 20;28(3):375-9
references.pmid: 20008645
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: J Clin Pathol. 1986 Sep;39(9):977-80
references.pmid: 3020096
references.citation: Br J Cancer. 2009 Oct 20;101(8):1253-60
references.pmid: 19755984
references.citation: Cancer. 1991 Jan 15;67(2):463-71
references.pmid: 1985739
references.citation: Nature. 2009 Dec 24;462(7276):1005-10
references.pmid: 20033038
references.citation: J Natl Cancer Inst. 2006 Feb 15;98(4):262-72
references.pmid: 16478745
references.citation: N Engl J Med. 2006 Aug 10;355(6):560-9
references.pmid: 16899776
references.citation: Oncogene. 2009 Feb 12;28(6):803-14
references.pmid: 19060928
references.citation: Lancet. 2003 Aug 2;362(9381):362-9
references.pmid: 12907009
references.citation: Cancer Res. 2001 Mar 15;61(6):2505-12
references.pmid: 11289122
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
references.pmid: 16141321
references.citation: J Clin Oncol. 2005 Oct 20;23(30):7483-90
references.pmid: 16234514
references.citation: Ann Oncol. 2009 Jun;20(6):1026-31
references.pmid: 19179558
references.citation: BMC Cancer. 2009 Mar 19;9:86
references.pmid: 19298662
references.citation: Science. 1987 Jan 9;235(4785):177-82
references.pmid: 3798106
references.citation: N Engl J Med. 1978 Jun 1;298(22):1223-8
references.pmid: 651963
references.citation: Science. 1989 Feb 17;243(4893):937-40
references.pmid: 2521957
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2552-8
references.pmid: 19318484
references.citation: Med Mol Morphol. 2009 Jun;42(2):128-31
references.pmid: 19536621
references.citation: J Clin Oncol. 2006 Apr 20;24(12):1839-45
references.pmid: 16622258
references.citation: J Clin Oncol. 1999 Feb;17(2):460-9
references.pmid: 10080586
references.citation: Crit Rev Oncol Hematol. 1995 Nov;21(1-3):158-93
references.pmid: 8822501
references.citation: Br J Cancer. 2005 Jan 17;92(1):147-55
references.pmid: 15611798
references.citation: J Clin Oncol. 2005 Jan 20;23(3):422-31
references.pmid: 15659489
references.citation: Med Oncol. 2009;26(3):344-9
references.pmid: 19016009
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8
references.pmid: 12917485
references.citation: J Clin Oncol. 1999 Oct;17(10):3058-63
references.pmid: 10506600
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43
references.pmid: 15701700
references.citation: Br J Cancer. 2004 Dec 13;91(12):2012-7
references.pmid: 15558072
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
references.pmid: 12829800
references.citation: Clin Oncol (R Coll Radiol). 2009 Aug;21(6):448-50
references.pmid: 19249193
references.citation: Cancer Res. 1976 Dec;36(12):4595-601
references.pmid: 1000504
references.citation: Lancet. 2002 Sep 14;360(9336):852-4
references.pmid: 12243922
references.citation: Nature. 2006 Jan 19;439(7074):353-7
references.pmid: 16273092
references.citation: Nature. 2002 Jan 31;415(6871):530-6
references.pmid: 11823860
references.citation: Endocr Relat Cancer. 2003 Mar;10(1):1-21
references.pmid: 12653668
references.citation: Clin Cancer Res. 2007 Apr 15;13(8):2329-34
references.pmid: 17438091
references.citation: J Clin Oncol. 2005 May 20;23(15):3331-42
references.pmid: 15908647
references.citation: Bioinformatics. 2005 Jan 15;21(2):171-8
references.pmid: 15308542
references.citation: Curr Cancer Drug Targets. 2009 May;9(3):419-38
references.pmid: 19442060
references.citation: Nat Med. 1996 Jul;2(7):811-4
references.pmid: 8673929
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1168-76
references.pmid: 19204205
references.citation: Lancet Oncol. 2009 Jun;10(6):581-8
references.pmid: 19394894
references.citation: Cancer. 2002 Jun 15;94(12):3107-14
references.pmid: 12115341
references.citation: Cancer Cell. 2007 Oct;12(4):395-402
references.pmid: 17936563
references.citation: Breast Cancer Res Treat. 1985;6(2):113-21
references.pmid: 4052638
references.citation: Nature. 2005 Apr 14;434(7035):917-21
references.pmid: 15829967
references.citation: Clin Cancer Res. 2000 Jan;6(1):50-6
references.pmid: 10656431
references.citation: J Clin Oncol. 2006 Aug 10;24(23):3726-34
references.pmid: 16720680
references.citation: Ann Oncol. 2007 Sep;18 Suppl 8:viii3-7
references.pmid: 17890212
references.citation: Ann Oncol. 2009 Nov;20(11):1813-7
references.pmid: 19553291
references.citation: N Engl J Med. 2006 May 18;354(20):2103-11
references.pmid: 16707747
references.citation: Cancer Res. 2002 Dec 1;62(23):7110-7
references.pmid: 12460933
references.citation: N Engl J Med. 2009 Jul 9;361(2):123-34
references.pmid: 19553641
references.citation: Lancet. 2005 May 14-20;365(9472):1687-717
references.pmid: 15894097
references.citation: Lancet Oncol. 2008 Jan;9(1):23-8
references.pmid: 18083065
references.citation: Lancet Oncol. 2003 Mar;4(3):177-85
references.pmid: 12623363
references.citation: Clin Cancer Res. 2009 Jun 15;15(12):4147-56
references.pmid: 19509167
references.citation: Nat Med. 2008 May;14(5):518-27
references.pmid: 18438415
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: N Engl J Med. 1978 Sep 14;299(11):604-5
references.pmid: 683230
references.citation: Cancer Res. 2009 Sep 1;69(17):6871-8
references.pmid: 19671800
references.citation: J Clin Oncol. 2008 Jun 20;26(18):3073-82
references.pmid: 18519949
references.citation: Ann Oncol. 2007 Aug;18(8):1293-306
references.pmid: 17317675
references.citation: J Clin Endocrinol Metab. 1995 Oct;80(10):2918-25
references.pmid: 7559875
references.citation: Clin Breast Cancer. 2008 Apr;8(2):124-33
references.pmid: 18621608
references.citation: Breast Cancer Res. 2009;11(3):206
references.pmid: 19519952
references.citation: Mol Oncol. 2010 Jun;4(3):284-300
references.pmid: 20466604
references.citation: Cancer Res. 2009 Aug 15;69(16):6660-7
references.pmid: 19654296
references.citation: J Natl Cancer Inst. 2009 May 20;101(10):736-50
references.pmid: 19436038
references.citation: Cancer. 2002 Aug 15;95(4):681-95
references.pmid: 12209710
references.citation: Cancer Cell. 2009 May 5;15(5):429-40
references.pmid: 19411071
references.citation: Clin Cancer Res. 2001 Jun;7(6):1577-81
references.pmid: 11410493
references.citation: PLoS Biol. 2005 Jun;3(6):e187
references.pmid: 15869330
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3430-6
references.pmid: 19470942
references.citation: Int J Cancer. 1999 Apr 12;81(2):309-13
references.pmid: 10188736
references.citation: J Clin Oncol. 2005 Oct 10;23(29):7265-77
references.pmid: 16145055
references.citation: Science. 1989 May 12;244(4905):707-12
references.pmid: 2470152
references.citation: Oncogene. 1997 Jul 31;15(5):537-47
references.pmid: 9247307
references.citation: Cancer Res. 2004 Dec 1;64(23):8558-65
references.pmid: 15574762
references.citation: Nat Rev Cancer. 2009 Feb;9(2):128-34
references.pmid: 19132008
references.citation: Breast Cancer Res Treat. 2010 May;121(1):53-64
references.pmid: 19593635
references.citation: Mod Pathol. 2010 Jan;23(1):62-70
references.pmid: 19767729
references.citation: Hum Mutat. 2008 Feb;29(2):284-8
references.pmid: 18022911
references.citation: Lancet. 2005 Feb 19-25;365(9460):671-9
references.pmid: 15721472
references.citation: Ann Oncol. 2000 Aug;11(8):1057-9
references.pmid: 11038046
references.citation: Cell. 1993 Sep 24;74(6):957-67
references.pmid: 8402885
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1160-7
references.pmid: 19204204
references.citation: Cancer. 1983 Mar 1;51(5):803-7
references.pmid: 6687378
references.citation: Nat Med. 2009 Jan;15(1):68-74
references.pmid: 19122658
references.citation: J Clin Oncol. 2004 Jun 15;22(12):2284-93
references.pmid: 15136595
references.citation: Clin Cancer Res. 2003 Nov 15;9(15):5582-8
references.pmid: 14654539
references.citation: Nature. 2009 Apr 9;458(7239):719-24
references.pmid: 19360079
references.citation: Oncogene. 2008 Sep 18;27(42):5648-50
references.pmid: 18504432
references.citation: Nat Clin Pract Oncol. 2005 Jan;2(1):26-33
references.pmid: 16264853
references.citation: J Clin Oncol. 2006 Mar 1;24(7):1045-51
references.pmid: 16476708
references.citation: Br J Cancer. 2006 Feb 27;94(4):455-9
references.pmid: 16449998
references.citation: J Clin Oncol. 2007 Sep 1;25(25):3816-22
references.pmid: 17679728
references.citation: J Natl Cancer Inst. 1998 Sep 16;90(18):1361-70
references.pmid: 9747867
references.citation: Cancer. 1980 Dec 15;46(12 Suppl):2809-13
references.pmid: 7004625
references.citation: J Clin Oncol. 2001 Sep 15;19(18):3808-16
references.pmid: 11559718
references.citation: Nat Med. 2006 Nov;12(11):1294-300
references.pmid: 17057710
references.citation: Breast Cancer Res Treat. 2008 Sep;111(1):27-44
references.pmid: 17922188
references.citation: Cancer. 1983 Nov 1;52(9):1551-7
references.pmid: 6352003
references.citation: J Clin Oncol. 2006 Jun 1;24(16):2428-36
references.pmid: 16682728
references.citation: J Clin Oncol. 2002 Mar 15;20(6):1467-72
references.pmid: 11896093
references.citation: Breast Cancer Res. 2008;10(6):R97
references.pmid: 19025652
references.citation: Breast Cancer Res Treat. 2010 Feb;119(3):551-8
references.pmid: 19214742
references.citation: Cancer. 2008 Nov 15;113(10):2638-45
references.pmid: 18833576
references.citation: Eur J Cancer. 2004 Jul;40(10):1502-8
references.pmid: 15196533
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):5678-85
references.pmid: 16115903
references.citation: Breast Cancer Res Treat. 2009 May;115(2):359-63
references.pmid: 18649131
references.citation: JAMA. 2006 Apr 12;295(14):1658-67
references.pmid: 16609087
references.citation: J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59
references.pmid: 16333030
references.citation: Eur J Cancer. 2004 Aug;40(12):1837-41
references.pmid: 15288284
references.citation: Br J Cancer. 2008 Jan 29;98(2):277-81
references.pmid: 18182985
references.citation: Nature. 2008 Feb 28;451(7182):1111-5
references.pmid: 18264088
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: J Clin Oncol. 1988 Jul;6(7):1076-87
references.pmid: 2856862
references.citation: Cancer. 1984 Oct 15;54(8):1586-90
references.pmid: 6478400
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1059-65
references.pmid: 18227529
references.citation: J Clin Oncol. 2010 Mar 1;28(7):1145-53
references.pmid: 20100965
references.citation: Breast Cancer Res Treat. 2001 May;67(2):111-6
references.pmid: 11519859
references.citation: J Clin Oncol. 2001 Jan 1;19(1):28-36
references.pmid: 11134192
references.citation: Am J Surg. 2009 Oct;198(4):520-5
references.pmid: 19800460
references.citation: BMC Cancer. 2006 Dec 06;6:276
references.pmid: 17150101
references.citation: Clin Cancer Res. 2007 Feb 15;13(4):1198-207
references.pmid: 17317830
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84
references.pmid: 18971340
references.citation: Pathobiology. 2008;75(2):85-94
references.pmid: 18544963
references.citation: Breast Cancer Res Treat. 2009 Jul;116(2):273-9
references.pmid: 18629632
references.citation: Oncogene. 2007 Mar 29;26(14):2126-32
references.pmid: 17016441
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2302-10
references.pmid: 19318481
references.citation: J Clin Oncol. 2009 Jun 10;27(17):2809-15
references.pmid: 19380452
references.citation: Bone Marrow Transplant. 2004 May;33(9):913-20
references.pmid: 15004544
references.citation: J Clin Oncol. 2008 Sep 1;26(25):4063-71
references.pmid: 18678838
references.citation: N Engl J Med. 2005 Oct 20;353(16):1659-72
references.pmid: 16236737
references.citation: Nature. 2008 Feb 28;451(7182):1116-20
references.pmid: 18264087
references.citation: J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92
references.pmid: 16954471
references.citation: Cancer Cell. 2004 Jun;5(6):607-16
references.pmid: 15193263
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: Fam Cancer. 2009;8(3):173-7
references.pmid: 19016350
references.citation: Clin Cancer Res. 2008 Mar 1;14(5):1368-76
references.pmid: 18316557
references.citation: Science. 1994 Oct 7;266(5182):66-71
references.pmid: 7545954
references.citation: Am J Pathol. 2000 Mar;156(3):839-47
references.pmid: 10702400
references.citation: J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):102-10
references.pmid: 17616457
references.citation: Curr Opin Pharmacol. 2008 Aug;8(4):363-9
references.pmid: 18644251
references.citation: N Engl J Med. 2002 Dec 19;347(25):1999-2009
references.pmid: 12490681
references.citation: Curr Opin Genet Dev. 2008 Feb;18(1):80-6
references.pmid: 18343102
references.citation: Science. 1994 Sep 30;265(5181):2088-90
references.pmid: 8091231
references.citation: Lancet Oncol. 2009 Mar;10(3):267-77
references.pmid: 19261255
references.citation: Lancet Oncol. 2010 Jan;11(1):55-65
references.pmid: 20005174
references.citation: N Engl J Med. 1994 May 5;330(18):1260-6
references.pmid: 7908410
references.citation: J Clin Oncol. 2009 Jul 1;27(19):3185-91
references.pmid: 19364972
references.citation: J Natl Cancer Inst. 2009 May 6;101(9):644-50
references.pmid: 19401546
references.citation: J Clin Oncol. 2006 Sep 10;24(26):4236-44
references.pmid: 16896004
references.citation: PLoS One. 2008 Aug 26;3(8):e3062
references.pmid: 18725978
references.citation: PLoS One. 2008 Apr 02;3(4):e1908
references.pmid: 18382681
references.citation: Nature. 2009 Oct 8;461(7265):809-13
references.pmid: 19812674
references.citation: Mol Cell Proteomics. 2004 Apr;3(4):379-98
references.pmid: 14762215
references.citation: Int J Cancer. 2009 Nov 1;125(9):2236-8
references.pmid: 19618461
references.citation: J Clin Oncol. 2009 Nov 20;27(33):5538-46
references.pmid: 19786658
references.citation: Trends Mol Med. 2004 Mar;10(3):113-8
references.pmid: 15102353
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: Genome Biol. 2007;8(5):R76
references.pmid: 17493263
references.citation: JAMA. 2006 Jun 7;295(21):2492-502
references.pmid: 16757721
references.citation: J Clin Oncol. 2008 Feb 10;26(5):778-85
references.pmid: 18258986
references.citation: Br J Cancer. 2003 Apr 22;88(8):1285-91
references.pmid: 12698198
references.citation: J Clin Oncol. 2010 Jan 20;28(3):361-3
references.pmid: 20008634
references.citation: J Clin Oncol. 2008 Mar 10;26(8):1275-81
references.pmid: 18250347
references.citation: J Clin Oncol. 1999 Sep;17(9):2639-48
references.pmid: 10561337
references.citation: BMC Genomics. 2006 Apr 27;7:96
references.pmid: 16643655
references.citation: N Engl J Med. 2001 Feb 22;344(8):539-48
references.pmid: 11207349
references.citation: BMC Genomics. 2006 May 26;7:127
references.pmid: 16729877
references.citation: Eur J Cancer. 2003 Mar;39(4):438-46
references.pmid: 12751373